openPR Logo
Press release

Denosumab Market Key Trends, Insights, Analysis 2024-2033: A Comprehensive Report

07-08-2024 12:23 PM CET | Health & Medicine

Press release from: The Business research company

Denosumab Market Key Trends

Denosumab Market Key Trends

"The new report published by The Business Research Company, titled "" Denosumab Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the denosumab market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The denosumab market size is expected to see rapid growth in the next few years. It will grow to $5.06 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13835&type=smp

Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence
The increasing prevalence of osteoporosis is expected to propel the growth of the denosumab market going forward. Osteoporosis is a medical condition where the bones become weak, resulting in lower bone density and a higher risk of fractures. Denosumab is used to treat osteoporosis by stopping bone resorption through the targeting of the RANK ligand. For instance, In December 2023, according to a report published by the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, osteoporosis contributed to 2,366 deaths, or 6.5 deaths per 100,000 population in 2021, representing 1.4% of all deaths. Further, in 2021-22, there were 9,500 hospitalizations with a principal diagnosis of osteoporosis (89 hospitalizations per 100,000 population) for people aged 45 and over. Therefore, the increasing prevalence of osteoporosis is driving the growth of the denosumab market.

Emphasis On First-Line Denosumab Treatments For Osteoporosis
Major companies operating in the denosumab market are increasing their focus on introducing innovative solutions, such as first-line treatments for osteoporosis, to gain a competitive edge in the market. First-line treatment for osteoporosis refers to the initial or primary therapeutic approach recommended by healthcare professionals when managing individuals diagnosed with osteoporosis. For instance, in November 2022, Boan Biotech, a China-based biotechnology company, received approval from China's National Medical Products Administration (NMPA) for its denosumab biosimilar, Boyoubei, making it the first Chinese company to develop a denosumab injection. It is also being developed for markets outside of China, including Europe and the United States, with plans for global marketing. The drug has been recommended as a first-line treatment for osteoporosis in various treatment guidelines. The medication has the potential to dramatically lower the risk of hip, non-vertebral, and vertebral fractures in this patient population. Additionally, Boyoubei is the first biosimilar to Prolia (the originator of denosumab) approved for marketing in the world.

The denosumab market covered in this report is segmented -

1) By Drug Classification: Prolia, Xgeva, Others
2) By Type: 60 mg, 120 mg
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13835&type=discount

Major companies operating in the denosumab market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Novartis International AG, Sanofi SA, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Asahi Kasei Corporation, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Limited, Mylan N.V., Sandoz International GmbH, Daiichi Sankyo Company Limited, Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Celltrion Inc., Amneal Pharmaceuticals Inc, Cadila Healthcare Limited, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Jubilant Life Sciences Limited, Ajanta Pharma Limited

Contents of the report:
1. Executive Summary
2. Denosumab Market Report Structure
3. Denosumab Market Trends And Strategies
4. Denosumab Market - Macro Economic Scenario
5. Denosumab Market Size And Growth
…..
27. Denosumab Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/denosumab-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Denosumab Market Key Trends, Insights, Analysis 2024-2033: A Comprehensive Report here

News-ID: 3570032 • Views:

More Releases from The Business research company

Technological Advancements With App Based Subscription Programs Industry Trends Gaining Momentum in the Global Car Washing Service Market
Technological Advancements With App Based Subscription Programs Industry Trends …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Car Washing Service Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent years, the car washing service market size has been expanding at a consistent rate. It is projected that from $30.1 billion in 2024, it will surge to $30.75 billion in 2025, with
Major Growth Driver Identified in 2025 Well Intervention Market: Rising Energy Demand Fuels Growth In The Well Intervention Market
Major Growth Driver Identified in 2025 Well Intervention Market: Rising Energy D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Well Intervention Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The size of the well intervention market has seen consistent growth over the past few years. The market, which will increase from $9.39 billion in 2024 to $9.84 billion in 2025 at a compound annual
Growing E-Commerce Sector Fuels Demand For Telephone Call Centers: Critical Driver Shaping the Telephone Call Centers Market in 2025
Growing E-Commerce Sector Fuels Demand For Telephone Call Centers: Critical Driv …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Telephone Call Centers Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for telephone call centers has seen a slight rise in recent years. The market value is predicted to increase from $136.61 billion in 2024 to $138.62 billion in 2025, maintaining a compound
Private Household Services Market Expansion Continues, with Forecast Valuation of $516.53 Billion by 2029
Private Household Services Market Expansion Continues, with Forecast Valuation o …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Private Household Services Market Size Valuation Forecast: What Will the Market Be Worth by 2025? There has been a significant expansion in the private household services market size in the past few years. This market will see an escalation from $321.58 billion in 2024 to $351.99 billion in 2025,

All 5 Releases


More Releases for Denosumab

Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: Strategic Insi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Denosumab Market Size By 2025? The market for denosumab has seen significant expansion in recent times. The growth is expected to rise from $3.27 billion in 2024 to $3.67 billion in 2025, portraying a compound annual growth rate (CAGR) of 12.1%. The increase during the
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: A Key Driver P …
The Denosumab Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Denosumab Market Size and Its Estimated Growth Rate? The market size of denosumab has seen a fast-paced expansion in the past few years. It is projected to surge from $3.27 billion in
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: Major Factor i …
How Will the Denosumab Market Grow, and What Is the Projected Market Size? The denosumab market is expected to grow from $3.27 billion in 2024 to $3.7 billion in 2025, at a CAGR of 13.1%. Clinical trials, research advancements, and growing awareness of bone health are key drivers. The denosumab market is expected to grow rapidly, reaching $5.59 billion by 2029, with a CAGR of 10.9%. This growth is attributed to the
Denosumab Market Size, Share, Trends, Insights And Forecast To 2033
The Business Research Company recently released a comprehensive report on the Global Denosumab Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The denosumab market size has grown
Denosumab Global Market Analysis, Trends, Growth, Research And Forecast 2033
The denosumab market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to clinical trials and research advancements, FDA approvals and regulatory milestones, growing awareness of bone health, strategic partnerships and marketing initiatives. The denosumab market size is expected to see
Denosumab Market Report, Size, Share And Analysis 2024-2033
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033. The Business Research Company presents an extensive market research report on the Denosumab Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing